Your SlideShare is downloading. ×
PowerPoint
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

PowerPoint

354
views

Published on


0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
354
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. MAT Cluster Development & Research Collaborations in Ontario Peter Goodhand Managing Director
  • 2. Medical Device A medical device is a product that is manufactured, sold or represented for use by humans in the Diagnosis, treatment, prevention or mitigation of a disease, disorder or abnormal physical state or symptoms thereof restoration, correction or modification of a body function or structure; Diagnosis of pregnancy; Care during pregnancy, and at or after the birth of the offspring, including the care of offspring; and, Prevention of conception or pregnancy. Assistive Device Any item, piece of equipment, or product system, whether acquired commercially, modified, or customized, that is used to increase, maintain, or improve the functional capabilities of individuals with disabilities and seniors. Diagnostics Equipment, tests, reagents for clinical diagnostics, including in-vitro, in-vivo, point of care, but excluding imaging. Imaging All types of medical and diagnostic imaging including - x-ray, CT scan, PET scan, MRI and Nuclear medicine.
  • 3. 2002 Market Value US$ 658 billion US market share = 46% Canada market share = 3%
  • 4. 73% 9% 9% 9% Medical Diagnostics Imaging Assistive Global MAT Market $225 Billion
  • 5. • Medical, Assistive, Diagnostic and Imaging -95% • Goods and Service providers -50% • The Goods category represents the component manufacturers and suppliers. • The service category represents consultants, lawyers and engineers. 0 50 100 150 200 250 300 M A D I G S Ontario Profile
  • 6. • Companies can be in more than one category since it is a listing of all their business activities. 0 50 100 150 200 250 300 350 400 450 M anufaturing R & D D istribution Exporters
  • 7. • 74% Canadian owned • 18% American owned • 8% owned by other countries. • Other includes; Germany, Japan, Sweden, Denmark, France, United Kingdom, Switzerland. 0 50 100 150 200 250 300 350 400 450 Canadian American Other
  • 8. • Small ($0-10 M) • Medium ($10-50 M) • Large ($50+M) 0 50 100 150 200 250 300 350 400 450 Small Medium Large
  • 9. Ontario in Global Context Cluster Total Companies Minnesota 900 UK 778 Ontario 723 San Diego 702 Massachusetts 603 Zurich 500 Rhine Valley 457 Maryland 275 Raleigh-Durham 200 Connecticut 110 Pittsburgh 90
  • 10. Ontario in Canadian Context
  • 11. Ontario by Major Cluster
  • 12. Ontario by BCiP
  • 13. MAT Companies in Ontario by BCIP Windsor London Guelph-Waterloo Golden Horseshoe Mississauga Toronto York Peterborough Kingston Ottawa and East Region Nothern Region
  • 14. MAT BioPharma Pharma ICT Aerospace Automotive Plastics
  • 15. Ontario Rehabilitation Technology Consortium A model of research collaboration
  • 16. Consortium Funding • Started in 1992 • 10 year commitment to be funded by the Ontario Ministry of Health and Long-Term Care • $1.5-million/year • Acquire matching funds of $750,000/year – $1,593,245 Avg. annual in cash – $1,401,566 Avg. annual in-kind contributions • $15-million matched by $29.9-million (2X)
  • 17. Address • Unmet needs through R&D in rehabilitation technology • Projects pertinent to safety, effectiveness, reliability and suitability for consumers • Promotion of Ontario industry in the field of assistive devices
  • 18. Partnerships • Researchers and developers – Academic institutions – Health care facilities • Industry • Clinicians • Ministry of Health and Long-Term Care, Ministry of Enterprise, Opportunity and Innovation, and Ministry of Citizenship • Consumers • Community
  • 19. Project Teams and Interlinking Components • Communication • Hearing • Mobility • Prosthetics and Orthotics • Respiration • Seating • Vision • Psychosocial Evaluation Team • Administration • Commercialization – Technology Transfer – Business Development – Trade Shows
  • 20. Partner Institutions – A first time collaboration • Bloorview MacMillan Children’s Centre (headquarters) • Centre for Studies in Aging, Sunnybrook and Women’s College Health Sciences Centre • Ontario Institute for Studies in Education • Queen’s University • University of Toronto • University of Waterloo • University of Western Ontario • West Park Healthcare Centre
  • 21. Consumer Relevance • Each Team incorporates consumer perspectives • Needs identified • Market perspective tested • Progress assessed • Methods: – Consumer panels – Conferences – Consumers working on the project
  • 22. Accomplishments • Products – 32 products to market – 15 products for licensing – 14 products in the pipeline • Intellectual Property – 29 patents awarded – 29 patents pending – 27 trademarks awarded • Job & Business Development – 31 active industrial partners – Contributed to the creation of 10 companies – 68 jobs created/sustained in industry for 2001-2002
  • 23. Publications and Training • Annual average of – 42 Refereed papers – 28 Conference proceedings – 54 Presentations – 12 Trade show exhibits • Establishment of web portal: www.assistivex.com • To date - Total of – 15 Ph.D. degrees awarded; 11 Ph.D. degrees in progress – 104 Masters degrees; 24 Masters degrees in progress
  • 24. A vital cultural shift • Researchers and developers interacting readily with industry • The job used to be done when the paper was generated • Now, the job isn’t done until the technology has been transferred!
  • 25. Peer Review Perspectives (June, 2001) • ORTC has achieved its commercialization objectives • Larger Ontario assistive devices industry • Strong partnerships among researchers, clinicians and industry • Leveraging of matching funds • High level of scientific publications • Rich environment for undergraduate/postgraduate study • Encourage discussions with other ministries on how development of assistive technologies can impact economic development and reduction of health care costs
  • 26. HEALTHCARESYSTEM START-UPEMERGING COMPANIES UNIVERSITIES A Broad Perspective and Integrated Services PRIVATE •Owner Operated Company •Importer/Exporter Hybrids •Distributors •Manufacturers •Low to Medium Technology •Minimal R&D PRIVATE/PUBLIC FUNDED •Professionally Managed •Manufacturing, Medium-High Technology, R&D CANADIANME’S GROWTH/INTERNATIONAL CANADIANMULTI-NATIONALS ForeignMulti-Nationals HTX Licensing Company Creation & Growth
  • 27. Vision “HTX will become the leading resource and catalyst for accelerating the growth of Ontario’s medical and assistive technologies industry cluster, ensuring Canada’s position as a global leader in commercializing related innovation technologies.” Mission “HTX supports the growth of a dynamic, prosperous Ontario medical and assistive technologies industry sector that aligns with and advances world class health care, enabling enhanced healthy living for its citizens.”
  • 28. Home Page
  • 29. Participant Home Page
  • 30. Participant Search
  • 31. Opportunity Watch
  • 32. Current Status •Pilot Phase of htx.ca-The Health Technology Exchange •Located at Innovation Synergy Centre in Markham •Working with MEDT and 6 BCiPs to develop network cluster strategy for MAT - Strategic Plan by September 2004 •htx.ca – web portal approximately 500 registered users •Providing knowledge and relationship brokerage to core clients •Researchers •Entrepreneurs/Start-ups •SME’s
  • 33. Q & A